How I plan to Brexit-proof my stocks and shares ISA

Do you fear Brexit will hit the value of your investments? Here’s how I think you can use it to your advantage.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With hardline Brexiteers sounding more like the Walmington-on-Sea Home Guard every day, it’s hardly surprising if private investors are getting nervous.

If we walk away from the EU with no agreement in place, an economic panic is almost certain — and then where would we be? I’m hoping common sense will prevail, but I’m also thinking of ways to reduce any adverse effects on my investment portfolio.

For me, the key approach is to think internationally, and going for FTSE 100 stocks will pretty much have that sorted anyway as the great majority of our top companies are global in their outlook. But you might want to keep away from domestic-focused stocks like banks and housebuilders.

Contrarian

I’m not shunning them myself as the contrarian in me thinks they’re oversold due to excessively pessimistic sentiment. But my investment in Lloyds Banking Group hasn’t been a roaring success so far, and if sleeping easy at night is key for you, then you might want to avoid those two sectors.

Among the more obvious international contenders are, I think, our top oil and pharmaceuticals companies, and I see BP, Royal Dutch Shell, AstraZeneca and GlaxoSmithKline as being pretty much immune to the vagaries of the UK economy.

Only around 25% of AstraZeneca’s turnover, for example, comes from the UK. GlaxoSmithKline is even better insulated, with a mere 5% or so generated on these shores.

Sterling

Those few bring me to two key considerations, world commodity prices and the value of the pound. Firstly, the harder our Brexit, the worse the impact on the currency is likely to be. But a falling pound should actually see share prices rising, as they reflect worldwide demand and are more closely tied to the US dollar than any other currency.

But more than that, commodities are priced in dollars, with the vast bulk of valuable dirt produced and consumed outside our islands. That means producers of oil, metals and minerals should be seeing the value of their revenues rising in sterling terms — and that should mean bigger profits and higher sterling share prices.

On that score, I’m happy with my investment in Sirius Minerals. It’s very much a UK-based company (with its potash assets in Yorkshire), but the sale agreements it has in place are with customers scattered around the globe. Sirius faces risks, but I don’t see Brexit as one of them.

Trusts

If you want more than ‘boring’ FTSE 100 shares, an option is to go for globally-based investment trusts. I love the idea of investment trusts anyway, where shareholders own all of their assets and there’s no conflict of interest between them and customers — because they’re one and the same. And they can provide a nice way to gain exposure to smaller global companies.

Lindsell Train Investment Trust, for example, has consistently been a strong performer, investing in a wide range of assets. Its shares are trading at a sizeable premium to net asset value, mind, so a lot of people probably have the same idea.

Witan Investment Trust and F&C Global Smaller Companies are two more with successful records, giving you options to target larger multinationals or smaller companies respectively. And there are plenty more great investment trusts out there.

Just remember one thing when it comes to Brexit — don’t panic.

Alan Oscroft owns shares of Lloyds Banking Group and Sirius Minerals. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Are Barclays shares trading at a 50% discount?

On some metrics, Barclays shares could be looked at as half price. Is this a fair way to look at…

Read more »

Landlady greets regular at real ale pub
Investing Articles

After toppling 11%, are Wetherspoons shares too cheap to miss?

Wetherspoons shares are sinking after a disappointing trading update on Friday (20 March). Is the FTSE 250 firm now a…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

2 S&P 500 tech titans to consider for a Stocks and Shares ISA 

Our writer sees a few blue chips from the S&P 500 that are worth considering for a Stocks and Shares…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

JD Wetherspoon’s share price takes a sobering 10% dip!

JD Wetherspoon's share price tanked today (20 March), after the pub chain published its latest results. James Beard reckons it’s…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

I asked ChatGPT when the Taylor Wimpey shares turnaround is coming and it said…

Taylor Wimpey shares have fallen a long way from all-time highs. Might a stunning recovery be on the cards for…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

My JD Wetherspoon shares just fell 12% in a day! Here’s what I’m doing

JD Wetherspoon shares just fell sharply on news of lower profits. But are these short-term challenges or is there a…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Nvidia stock price forecast: could we see $300 in 2026?

Nvidia stock has paused for breath recently. However, Wall Street analysts seem to believe that it’s just a matter of…

Read more »

Older Man Reading From Tablet
Investing Articles

How to shelter a SIPP from a nasty stock market crash

Edward Sheldon outlines some simple strategies that could help SIPP investors protect their wealth against an equity market meltdown.

Read more »